Los Angeles Capital Management
ZYME icon

Los Angeles Capital Management’s Zymeworks ZYME Stock Holding History

Los Angeles Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Sell
18,267
-21,483
-54% -$546K ﹤0.01% 926
2026
Q1 		$995K Buy
39,750
+39,363
+10,171% +$931K ﹤0.01% 683
2025
Q4 		$7.4K Buy
+387
New +$8.44K ﹤0.01% 2183

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Los Angeles Capital Management's ZYME Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Zymeworks (ZYME) stake by 54% in Q2 2026, selling an estimated $546K and leaving 18,267 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Los Angeles Capital Management first reported a position in ZYME in Q4 2025 and has held it in 3 quarters since. The position peaked at $995K in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Los Angeles Capital Management held 18,267 shares of Zymeworks worth $477K as of Q2 2026.
  • Los Angeles Capital Management sold 21,483 Zymeworks shares in Q2 2026, an estimated $546K.
  • Zymeworks made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #926 holding.
  • Los Angeles Capital Management first reported a position in Zymeworks in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's Zymeworks position peaked at $995K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.